Adial Pharmaceuticals, Inc. (ADIL)Healthcare | Biotechnology | Glen Allen, United States | NasdaqCM
1.63 USD
+0.00
(0.309%)
⇧
(April 17, 2026, 3:38 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:32 p.m. EDT
ADIL is currently experiencing significant volatility and uncertainty, with a recent price drop following a reverse stock split announcement. The stock's low price-to-book ratio and negative earnings suggest potential undervaluation, but the lack of consistent dividend payments and high financial risks make it unsuitable for long-term investment. Short-term traders may consider the recent dip as a buying opportunity, but the high beta and negative momentum indicators indicate a risky environment. Overall, ADIL is not a strong candidate for either short-term or long-term investment at this time. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.740990 |
| AutoTheta | 0.803906 |
| MSTL | 0.938431 |
| AutoETS | 0.940083 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 2.99 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.62 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 2,320,451 |
| Forward P/E | -0.34 |
| Beta | 1.40 |
| Website | https://www.adial.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9003077 |
| Address1 | 4,870 Sadler Road |
| Address2 | Suite 300 |
| All Time High | 5,900.0 |
| All Time Low | 1.54 |
| Ask | 1.64 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 93,600 |
| Average Daily Volume3 Month | 96,967 |
| Average Volume | 96,967 |
| Average Volume10Days | 93,600 |
| Beta | 1.399 |
| Bid | 1.58 |
| Bid Size | 1 |
| Book Value | 4.749 |
| City | Glen Allen |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.625 |
| Current Ratio | 4.425 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.655 |
| Day Low | 1.61 |
| Display Name | Adial Pharmaceuticals |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -7,798,897 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.457 |
| Enterprise Value | -3,567,905 |
| Eps Current Year | -6.59333 |
| Eps Forward | -4.795 |
| Eps Trailing Twelve Months | -11.93 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.1454 |
| Fifty Day Average Change | -0.52040005 |
| Fifty Day Average Change Percent | -0.24256551 |
| Fifty Two Week Change Percent | -90.03077 |
| Fifty Two Week High | 30.25 |
| Fifty Two Week High Change | -28.625 |
| Fifty Two Week High Change Percent | -0.946281 |
| Fifty Two Week Low | 1.54 |
| Fifty Two Week Low Change | 0.08500004 |
| Fifty Two Week Low Change Percent | 0.055194832 |
| Fifty Two Week Range | 1.54 - 30.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,532,698,200,000 |
| Float Shares | 1,284,202 |
| Forward Eps | -4.795 |
| Forward P E | -0.33889467 |
| Free Cashflow | -3,768,275 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07993 |
| Held Percent Institutions | 0.09906 |
| Implied Shares Outstanding | 1,427,970 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,770,336,000 |
| Last Split Factor | 1:25 |
| Long Business Summary | Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia. |
| Long Name | Adial Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 2,320,451 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_112638788 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -7,977,171 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,299,031 |
| Number Of Analyst Opinions | 3 |
| Open | 1.6308 |
| Operating Cashflow | -6,492,603 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 804 487 8196 |
| Previous Close | 1.62 |
| Price Eps Current Year | -0.2464612 |
| Price Hint | 4 |
| Price To Book | 0.3421773 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.21 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.004999995 |
| Regular Market Change Percent | 0.30864167 |
| Regular Market Day High | 1.655 |
| Regular Market Day Low | 1.61 |
| Regular Market Day Range | 1.61 - 1.655 |
| Regular Market Open | 1.6308 |
| Regular Market Previous Close | 1.62 |
| Regular Market Price | 1.625 |
| Regular Market Time | 1,776,454,680 |
| Regular Market Volume | 68,437 |
| Return On Assets | -0.83205 |
| Return On Equity | -1.7073399 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,427,970 |
| Shares Percent Shares Out | 0.0678 |
| Shares Short | 96,887 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 27,868 |
| Short Name | Adial Pharmaceuticals, Inc |
| Short Percent Of Float | 0.0684 |
| Short Ratio | 0.62 |
| Source Interval | 15 |
| State | VA |
| Symbol | ADIL |
| Target High Price | 42.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 23.33333 |
| Target Median Price | 20.0 |
| Total Cash | 5,881,217 |
| Total Cash Per Share | 4.119 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -11.93 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.8751 |
| Two Hundred Day Average Change | -5.2501 |
| Two Hundred Day Average Change Percent | -0.7636398 |
| Type Disp | Equity |
| Volume | 68,437 |
| Website | https://www.adial.com |
| Zip | 23,060 |